Effect of gingerol on substance P and NK1 receptor expression in a vomiting model of mink

Chinese Medical Journal

Volumn 123, Issue 4, 2010, Pages 478-484

  Qian, Qiu Hai ^a,b   Yue, Wang ^b   Chen, Wen Hui ^c   Yang, Zhi Hong ^b   Liu, Zhan Tao ^b   Wang, Yao Xia ^b  

^a SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^c Guangxi College of Traditional Chinese Medicine   (China)

Author keywords

Cisplatin; Gingerol; Mink; NK1 receptors; Substance P; Vomiting

Indexed keywords

CISPLATIN; GINGEROL; NEUROKININ 1 RECEPTOR; ONDANSETRON; SUBSTANCE P;

ANIMAL MODEL; ANTIEMETIC ACTIVITY; AREA POSTREMA; ARTICLE; CONTROLLED STUDY; GINGER; ILEUM MUCOSA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEDICINAL PLANT; MINK; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; RETCHING; SUBMUCOSA; VOMITING; WESTERN BLOTTING;

ANIMALS; AREA POSTREMA; BLOTTING, WESTERN; CATECHOLS; DISEASE MODELS, ANIMAL; FATTY ALCOHOLS; ILEUM; IMMUNOHISTOCHEMISTRY; MALE; MINK; RECEPTORS, NEUROKININ-1; SUBSTANCE P; VOMITING;

EID: 77149133081     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.04.017     Document Type: Article

References (33)

1. Hickok TJ, Morrow GR. A biobehavioral model of patient reported nausea: implications for clinical practise. Adv Med Psychother 1993; 6: 227-230.
2. Fiore JJ, Gralla RJ. Pharmacologic treatment of chemotherapy-induced nausea and vomiting. Cancer Invest 1984; 2: 351-361.
3. Morrow GR. Chemotherapy-related nausea and vomiting: etiology and management. CA Cancer J Clin 1989; 39: 89-104.
4. Morrow GR, Hickok JT, Rosenthal SN. Progress in reducing nausea and emesis. Cancer 1995; 76: 343-357.
5. Gandara DR, Harvey WH, Monaghan GG, Perez EA, Hesketh PJ. Delayed emesis following high-dose cisplatin a double-blind randomised comparative trial of ondansetron GR-38032F versus placebo. Eur J Cancer 1993; 29A: S35-S38.
6. Kris MG, Tyson LB, Clark RA, Gralla RJ. Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase-II study and a review of completed trails to manage delayed emesis. Cancer 1992; 70: 1012-1016.
7. Bountra C, Bunce K, Dale T, Gardner C, Jordan C, Twissell D, et al. Anti-emetic profile of a non-peptideneurokinin NK1 receptor antagonist, CP-99,994, in ferrets. Eur J Pharmacol 1993; 249: R3-R4.
8. Tattersall FD, Rycroft W, Hill RG, Hargreaves RJ. Enantioselective inhibition of apomorphine-induced emesis in the ferret by the neuokinin1 receptor antagonist CP-99,994. Neuropharmacology 1994; 33: 259-260.
9. Watson JW, Gonsalves SF, Fossa AA, McLean S, Seeger T, Obach S, et al. The anti-emetic effects of CP-99,994 in the ferret and dog: role of the NK1 receptor. Br J Pharmacol 1995; 115: 84-94.
10. Hesketh PJ, Van Belle S, Aapro M, Tattersall FD, Naylor RJ, Hargreaves R, et al. Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. Eur J Cancer 2003; 39: 1074-1080.
11. Andrews PLR, Rudd JA. The role of tachykinins and the tachykinin receptor in nausea and emesis. In: Holzer P (Ed.), Handbook of Experimental Pharmacology. Springer-Verlag Berlin Heidelberg: Germany; 2004: 359-440.
12. Leksowski K, Peryga P, Szyca R. Ondansetron, metoclopramid, dexamethason, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized study. Surg Endosc 2006; 20: 878-882.
13. Abali H, Celik I. Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost. Cancer Invest 2007; 25: 135-139.
14. Vutyavanich T, Kraisarin T, Ruangsri R. Ginger for nausea and vomiting in pregnancy: randomized double-masked placebo-controlled trial. Obstet Gynecol 2001; 4: 577-582.
15. Pongrojpaw D, Chiamchanya C. The efficacy of ginger in prevention of post-operative nausea and vomiting after outpatient gynecological laparoscopy. J Med Assoc Thai 2003; 3: 244-250.
16. Sharma SS, Kochupillai V, Gupta SK, Seth SD, Gupta YK. Antiemetic effcacy of ginger against cisplatin induced emsis in dogs. Ethnonharmacol 1997; 2: 93-96.
17. Zhao DX, Yang ZH, Li M, Xue M, Yue W. Anti-emetic effects of ginger on a nausea model of mink. Chin Pharm Affairs (Chin) 2006; 10: 601-604.
18. Jiang SZ, Mi SZ, Wang NS. Survey of chemical constituents of gingerol. Tradit Chin Drug Res Clin Pharmacol (Chin) 2006; 17: 386-389.
19. Abdel-Aziz H, Windeck T, Ploch M, Verspohl EJ. Mode of action of gingerols and shogaols on 5-HT3 receptors: binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum. Eur J Pharmacol 2006; 530: 136-143.
20. Zhang F, Wang L, Yang ZH, Yue W. Value of mink vomit model in study of anti-emetic drugs. World J Gastroenterol 2006; 12: 1300-1302.
21. Ferrier CM, de Witte HH, Straatman H, van Tienoven DH, van Geloof WL, Rietveld FJ, et al. Comparison of immunohistochemistry with immunoassay (ELISA) for the detection of components of the plasminogen activation system in human tumour tissue. Br J Cancer 1999; 79: 1534-1541.
22. Yuan ZL, Feng WY, Hong J, Zheng Q, Shuai J, Ge YB. p38MAPK and ERK promote nitric oxide production in cultured human retinal pigmented epithelial cells induced by high concentration glucose. Nitric Oxide 2009; 20: 9-15.
23. Leslie RA. Neuroactive substances in the dorsal vagal complex of the medulla oblongata: nucleus of the tractus solitarius, area postrema, and dosal motor nucleus of vagus. Neurochem Int 1985; 7: 191-211.
24. Nagashima A, Takano Y, Tateishi K, Matsuoka Y, Hamaoka T, Kamiya H. Cardiovascular roles of tachykinin peptides in the nucleus tractus solitarii of rats. Brain Res 1989; 487: 392-396.
25. Newton BW, Maley B, Traurig H. The distribution of substance P, enkephalin and serotonin immunoreactivities in the area postrema of the rat and cat. J Comp Neurol 1985; 234: 87-104.
26. Ramírez MJ, Cenarruzabeitia E, Del Río J, Lasheras B. Involvement of neurokinins in the non-cholinergic response to activation of 5-HT3- and 5-HT4-receptors in guinea pig ileum. Br J Pharmacol 1994; 111: 419-424.
27. Fukuda H, Koga T, Furukawa N, Nakamura E, Shiroshita Y. The tachykinin NK1 receptor antagonist GR205171 abolishes the retching activity of neurons comprising the central pattern generator for vomiting in dogs. Neurosci Res 1999; 33: 25-32.
28. Fukuda H, Nakamura E, Koga T, Furukawa N, Shiroshita Y. The site of the anti-emetic action of tachykinin NK1 receptor receptor antagonists may exist in the medullary area adjacent to the semicompact part of the nucleus ambiguus. Brain Res 1999; 818: 439-449.
29. Potts JT, Fuchs IE, Li J, Leshnower B, Mitchell JH. Skeletal muscle afferent fibres release substance P in the nucleus tractus solitarii of anaesthetized cats. J Physiol 1999; 514: 829-841.
30. Andrews PLR, Bhandari P. Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret. Neuropharmacology 1993; 32: 799-806.
31. Andrews PLR, Bhandari P. The 5-hydroxytryptamine receptor antagonists as antiemetics: preclinical evaluation and mechanism of action. Eur J Cancer 1993; 29: S11-S16.
32. Andrews PLR, Okada F, Woods AJ, Hagiwara H, Kakaimoto S, Toyoda M, et al. The emetic and anti-emetic effects of the capsaicin analogue resiniferatoxin in, the Suncus murinus house musk shrew. Br J Pharmacol 2000; 130: 1247-1254.
33. Surh YJ. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem Toxicol 2002; 40: 1091-1097.